Kim Robert Young bought FDMT
February 5, 2024 · Form 4 insider transaction
Kim Robert Young bought 6,000 shares of 4D Molecular Therapeutics, Inc. at $15.78 per share, a transaction worth $94.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,000
Price
$15.78
Total value
$94.7K
InsiderKim Robert Young
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 5, 2024
Filing dateFebruary 7, 2024
Shares owned after7,595
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 11, 2023.